<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="197162">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00524290</url>
  </required_header>
  <id_info>
    <org_study_id>PRO07080043</org_study_id>
    <nct_id>NCT00524290</nct_id>
  </id_info>
  <brief_title>Multinational Study of Acinetobacter Bloodstream Infection: Clinical Outcomes and Global Epidemiology-PITT Protocol</brief_title>
  <official_title>Multinational Study of Acinetobacter Bloodstream Infection: Clinical Outcomes and Global Epidemiology-PITT Protocol</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Pittsburgh</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Pittsburgh</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objectives of this multinational study are to assess the clinical outcomes of patients
      with Acinetobacter bloodstream infection and to further assess the predictors of mortality
      in this patient population. We also aim to characterize the molecular epidemiology of this
      remarkable organism in an attempt to further understand its transmission dynamics on a
      global level and to determine whether increased pathogenicity is geographically dependent.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Medical records will be reviewed and information collected to assess the clinical outcomes
      of patients with Acinetobacter bloodstream infection and to further assess the predictors of
      mortality in this patient population.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2009</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Acinetobacter Infections</condition>
  <eligibility>
    <study_pop>
      <textblock>
        acinetobacter infections
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with Acinetobacter infections

        Exclusion Criteria:

          -  Those that do not meet entry criteria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Paterson, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Pittsburgh</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>David Paterson, MD</last_name>
    <phone>412-648-6553</phone>
    <email>david.antibiotics@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Diana Lynn Pakstis, RN, BSN</last_name>
    <phone>412-648-6553</phone>
    <email>pakstisdl@dom.pitt.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University of Pittsburgh Medical Center</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David Paterson, MD</last_name>
      <phone>412-648-6553</phone>
      <email>david.antibiotics@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Diana Lynn Pakstis, RN, BSN</last_name>
      <phone>412-648-6553</phone>
      <email>pakstisdl@dom.pitt.edu</email>
    </contact_backup>
    <investigator>
      <last_name>David Paterson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anton Peleg, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2015</verification_date>
  <lastchanged_date>December 16, 2015</lastchanged_date>
  <firstreceived_date>August 31, 2007</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acinetobacter</keyword>
  <keyword>infection</keyword>
  <keyword>isolate</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Acinetobacter Infections</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
